180
Participants
Start Date
May 31, 2004
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
Lurasidone
80 mg AM dosing once daily
Placebo
Matching Placebo to 40mg lurasidone tablets
Quantum Clinical Services Group, Philadelphia
Comprehensive NeuroScience, Inc, Washington D.C.
CBH Health, L.L.C - Dominion Hospital, Falls Church
Atlanta Center for Medical Research, Atlanta
Segal Institute for Clinical Research, North Miami
The Segal Institute, North Miami
University of South Florida, Department of Psychiatry and Behavioral Medicine, Tampa
Birmingham Psychiatry Pharmaceutical, Birmingham
Comprehensive Neuroscience, Inc., Hoffman Estates
Summit Research Group, Little Rock
InSite Clinical Research, DeSoto
Claghorn-Lesem Research Clinic, Bellaire
Community Clinical Research, Austin
Future Search Trials, Austin
Robert Lynn Horne, MD, Suite 4, Las Vegas
Comprehensive NeuroScience, Cerritos
Pacific Clinical Research, Upland
Optimum Health Services, La Mesa
California Clinical Trials, San Diego
CNRI, LLC San Diego, San Diego
Collaborative Neuro Science Network, Inc., Garden Grove
CNS Research Institute, Clementon
Sumitomo Pharma America, Inc.
INDUSTRY